ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 116 filers reported holding ANAPTYSBIO INC in Q3 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $647,045 | -11.7% | 36,027 | -0.0% | 0.00% | 0.0% |
| Q2 2023 | $733,135 | -97.5% | 36,044 | -97.3% | 0.00% | -97.3% |
| Q1 2023 | $29,153,134 | -60.4% | 1,339,758 | -43.5% | 0.07% | -64.0% |
| Q4 2022 | $73,539,983 | +21.5% | 2,373,023 | +0.0% | 0.20% | +14.7% |
| Q3 2022 | $60,533,000 | +29.4% | 2,372,923 | +3.0% | 0.18% | +39.4% |
| Q2 2022 | $46,773,000 | +17.9% | 2,304,097 | +43.7% | 0.13% | +41.1% |
| Q1 2022 | $39,663,000 | -28.9% | 1,603,187 | -0.1% | 0.09% | -13.5% |
| Q4 2021 | $55,749,000 | +118.2% | 1,604,287 | +70.3% | 0.10% | +112.2% |
| Q3 2021 | $25,554,000 | +9.1% | 942,273 | +4.3% | 0.05% | +11.4% |
| Q2 2021 | $23,425,000 | -4.0% | 903,407 | -20.2% | 0.04% | -6.4% |
| Q1 2021 | $24,400,000 | -14.0% | 1,132,268 | -14.2% | 0.05% | -19.0% |
| Q4 2020 | $28,365,000 | +36.8% | 1,319,284 | -6.2% | 0.06% | +18.4% |
| Q3 2020 | $20,739,000 | -34.4% | 1,406,033 | -0.7% | 0.05% | -37.2% |
| Q2 2020 | $31,618,000 | +75.7% | 1,415,310 | +11.1% | 0.08% | +47.2% |
| Q1 2020 | $17,998,000 | -53.4% | 1,273,767 | -46.4% | 0.05% | -38.4% |
| Q4 2019 | $38,647,000 | -16.6% | 2,378,300 | +79.6% | 0.09% | -24.6% |
| Q3 2019 | $46,330,000 | -29.4% | 1,324,100 | +13.9% | 0.11% | -28.3% |
| Q2 2019 | $65,611,000 | +38.3% | 1,162,900 | +79.0% | 0.16% | +35.9% |
| Q1 2019 | $47,455,000 | +21.0% | 649,620 | +5.7% | 0.12% | +9.3% |
| Q4 2018 | $39,207,000 | -28.2% | 614,620 | +12.4% | 0.11% | -15.7% |
| Q3 2018 | $54,574,000 | +56.3% | 547,000 | +11.3% | 0.13% | +24.5% |
| Q2 2018 | $34,909,000 | -24.0% | 491,400 | +11.4% | 0.10% | -23.3% |
| Q1 2018 | $45,923,000 | +3.4% | 441,230 | +0.0% | 0.13% | +6.4% |
| Q4 2017 | $44,430,000 | +661.2% | 441,128 | +164.1% | 0.12% | +635.3% |
| Q3 2017 | $5,837,000 | +22.0% | 167,000 | -16.5% | 0.02% | +21.4% |
| Q2 2017 | $4,786,000 | -13.8% | 200,000 | 0.0% | 0.01% | -12.5% |
| Q1 2017 | $5,550,000 | – | 200,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |